1. http://www.med.ucalgary.ca/webs/oncology/research/openstudies.html
... chemotherapy (carbolatin/paclitaxel) for first line therapy of advanced ovarian or primary peritoneal carcinoma ALLOS RT -016 A phase III radomized , open-label comparative study of standard whole ...

2. Pelvic Mass/CA-125/Ultrasound
... Since the emailing woman had had her gynecologic organs removed, few doctors would immediately suspect that she might have such a rare type of carcinoma as peritoneal carcinoma (.16%), when colon ...
http://www.ohanlan.com/pelvic_mass.htm

3. Trials Portfolio
... triplet or sequential doublet combinations in patients with epithelial ovarian or primary peritoneal carcinoma. Home | About NCRN | News & Events | Education & Training | Trials Portfolio | Research ...
http://www.ncrn.org.uk/po ...pID=6&Status=3&type=0

4. Clinical Oncological Society of Australia
... Triplet or Sequential doublet combinations in patients with Epithelial Ovarian or Primary Peritoneal Carcinoma. Study Chair Michael Bookman. For more details regarding this group or to become a member ...
http://www.cosa.org.au/content.cfm?randid=867578

5. Clinical Cancer Research -- Table of Contents (June 1 2000, 6 [6])
... Interleukin 2 with or without Tumor-infiltrating Lymphocytes in Patients with Ovarian or Peritoneal Carcinoma Clin Cancer Res 2000 6: 2268-2278. [Abstract] [Full Text] [PDF] Giuseppe Toffoli, Roberto ...
http://clincancerres.aacr .../content/vol6/issue6/

6. Carcinoma Peritoneal
... Ovarian Peritoneal Cancer Peritoneal Cancer Peritoneal Primary Cancer Peritoneal Symptom Carcinoma Peritoneal Carcinomatosis Peritoneal Catheter Dialysis Peritoneal Catheter Peritoneal Cavity ...
http://peritoneal.mesothe .../carcinomaperitoneal/

7. Testing for Hereditary Risk of Ovarian Cancer
... 38,39 Most studies of this phenomenon were conducted before direct genetic testing for BRCA1 and BRCA2 was available, and consequently, there is little data regarding the risks of peritoneal carcinoma ...
http://www.moffitt.usf.ed ...ccj/v6n4/article1.htm

8. Word on Health Article - Usable News--Recent Press Releases - June 1998
... 9661). Ovarian or peritoneal cancer: This is a Phase II study of HerceptinÆ in recurrent or refractory ovarian or primary peritoneal carcinoma. Phase II studies test the effectiveness of a drug in ...
http://www.nih.gov/news/WordonHealth/jun98/pr2.htm

9. Welcome to gulfMD.com - The world of Health, Progress and Hope
... Other related conditions include primary peritoneal carcinoma (a type of cancer) and ovarian cysts (rarely cancerous). According to the American Cancer Society (ACS), ovarian cancer is the seventh ...
http://www.gulfmd.com/wom ...rian cancer.asp?id=33

10.
... GOG182: A Phase III Randomized Trial of Paclitaxel and Carboplatin Versus Triplet or Sequential Doublet Combinations in Patients with Epithelial Ovarian or Primary Peritoneal Carcinoma, PI J Curtin ...
http://www.med.nyu.edu/obgyn/research/

11. CancerNetwork.com:Cancer Screening, Diagnosis, and Treatment
... to Blood Disorder Gestational Trophoblastic Tumors Ovarian Cancer Extraovarian Primary Peritoneal Carcinoma BRCA2 Gene Mutations Linked to Ovarian Cancer Cases Overall Management Modern Management ...
http://www.cancernetwork.com/contents/ovarian.htm

12.
... Triplet or Sequential Doublet Combinations in Patients with Epithelial Ovarian or Primary Peritoneal Carcinoma GOG 146-O Phase II Evaluation of Irofulven in the Treatment of Recurrent or Persistent ...
http://www.jupitermed.com ...h/Clinical Trials.htm

13. Cancer Research and Prevention Foundation: Healthy Living - Cancer Informati...
... Primary peritoneal carcinoma is a cancer much like epithelial ovarian cancer but it starts outside of the ovaries. It grows from the cells that line the pelvis or abdomen. These cells look like the ...
http://www.preventcancer. ...ancerinfo/ovarian.cfm

14. UMIC: News & Announcements
... 1997). Nuclear Overexpression of p53 Protein does not Correlate with Gene Mutation in Primary Peritoneal Carcinoma. Human Pathol. 28:1002 -1006. Matic,M., Shibata, S., Fillit, H.M., (1997). Monoclonal ...
http://www.umic.sunysb.edu/news.htm

15. UCSD Cancer Center Clinical Trials
... Recurrence only Epithelial Ovarian Cancer, Cancer of the Fallopian Tube, and Primary Peritoneal Carcinoma after First Line Chemotherapy More... 031049 CALGB 10102: A Phase I/II Dose Escalation ...
http://www.cancer.ucsd.ed ...Trials/study_list.asp

16. In Vitro Chemoresistance and Chemosensitivity Assays
... Extreme drug resistance assay and response to chemotherapy in patients with primary peritoneal carcinoma. J Surg Oncol 2000; 73(3): 148-52 Mehta RS, Bornstein R, Yu IR. Breast cancer survival and in ...
http://www.regence.com/trgmedpol/lab/lab06.html

17. Latest Updates - New Medicine's Oncology KnowledgeBASE (nm|OK)
... Paclitaxel in Patients with Stage III or IV Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal Carcinoma NCCTG-N0234 Phase II Study of Erlotinib and Gemcitabine in Patients with Metastatic ...
http://nmok.net/updates/cmbthrJul05.html

18. Ovarian Cancer Research Advances
... Following First-Line Chemotherapy and a Rising CA125 Levels Ovarian Cancer; Primary Peritoneal Carcinoma 6) Fragmin in Ovarian Cancer: Utility on Survival (FOCUS) Ovarian Cancer 7) Removal of ...
http://www.ovarian-cancer-clinical-trials.com/

19. Tumor Immunology
... expression of class I MHC, possible cytostatic anti-tumor effect, IFN-gamma remission of peritoneal carcinoma of ovary: ineffective systemically increased MHC antigens; macrophage, Tc and NK cell ...
http://pathmicro.med.sc.e ...r/tumor_immunol00.htm

20. All Primary Peritoneal Carcinoma messages
... SM Cancer Community> Cancer Message Board> Message Message Board Discussions Primary Peritoneal Carcinoma Single Message View Recommend This Message Reply to This Message Subject: Primary ...
http://www.cancercompass. ...message/all,398,0.htm

21. Baylor College of Medicine OB/GYN
... interleukin 2 with or without tumor-infiltrating lymphocytes in patients with ovarian or peritoneal carcinoma. Clin Cancer Res. Jun;6(6):2268-78. 2000. 7. Verstovsek S, Verschraegen CF, Edwards CL ...
http://www.bcm.edu/obgyn/faculty_details.cfm?id=12

22. GYN_CCP_001
... Versus Carboplatin in Platinum-Sensitive Patients With Recurrent Epithelial Ovarian or Peritoneal Carcinoma After Failure of Initial Platinum-Based Chemotherapy C VMMC ENDOMETRIAL CANCER No active ...
http://www.niccresearch.org/pages/GYN_CCP_001.asp

23. Clinical Trials
... v. Thalidomide in Biochemical-Recurrence-Only Ovarian, Fallopian Tube, and Primary Peritoneal Carcinoma GOG 0212 Phase III Randomized Study of Maintanence Xyotax or Paclitaxel Versus No Treatment in ...
http://www.clevelandclini ...p?Disease=Gynecologic

24. Clinical Trials: Holden Comprehensive Cancer Center: UI Health Care
... IND #69,896) in the Treatment of Persistent or Recurrent Epithelial Ovarian or Primary Peritoneal Carcinoma (PI:Koen De Geest) Contact Sharon Stockman GOG #9917: A Dose-Escalating Phase I Study ...
http://www.uihealthcare.c ...onals/clintrials.html

25. MRC CTU - Browse All Research
... ISRCTN:47434271 Closed RCT ICON5: A five arm trial of triple or sequential doublet regimens in patients with ovarian or peritoneal carcinoma A randomised international 5-arm trial of carboplatin and ...
http://www.ctu.mrc.ac.uk/BrowseAll.asp

26. Marshall Edwards Inc. - Phenoxodiol
... Patients must have histological evidence of epithelial ovarian, fallopian or primary peritoneal carcinoma and have been previously surgically staged. Patients must have received no more than 4 ...
http://www.phenoxodiol.co ...ection=03&subsec=0316